AK Medical Holdings Limited Share Price

Equities

1789

KYG020141019

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 01:38:20 26/04/2024 pm IST 5-day change 1st Jan Change
5.77 HKD +4.15% Intraday chart for AK Medical Holdings Limited +19.96% -7.83%

Financials

Sales 2023 1.09B 151M 1.18B 12.59B Sales 2024 * 1.41B 195M 1.52B 16.22B Capitalization 5.99B 827M 6.47B 68.95B
Net income 2023 182M 25.12M 197M 2.09B Net income 2024 * 264M 36.43M 285M 3.04B EV / Sales 2023 5.84 x
Net cash position 2023 * 1.07B 148M 1.16B 12.36B Net cash position 2024 * 203M 27.98M 219M 2.33B EV / Sales 2024 * 4.11 x
P/E ratio 2023
35.6 x
P/E ratio 2024 *
22.7 x
Employees 1,052
Yield 2023 *
1.12%
Yield 2024 *
1.19%
Free-Float 48.64%
More Fundamentals * Assessed data
Dynamic Chart
AK Medical Holdings' Surgical Robot Gets NMPA's Nod MT
Eric Wang to Retire as an Independent Non-Executive Director of AK Medical Holdings Limited CI
AK Medical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024 CI
AK Medical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
AK Medical Secures Regulatory Nod For Pelvic Implant MT
Ak Medical Holdings Limited Obtains the Certification from National Medical Products Administration CI
AK Medical Gets Certification for Acetabular Component of Hip Prosthesis MT
AK Medical Holdings Limited Obtains the Certification for Acetabular Component of Hip Prosthesis Class III Medical Devices Approved by the National Medical Products Administration CI
China Grants Certification for AK Medical Holdings' Surgical Robotic Arm MT
AK Medical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
AK Medical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on or Around 18 July 2023 CI
Chinese Regulator Approves AK Medical's Certification for Prosthetis System MT
AK Medical Holdings Limited Obtains the Certification for the Metal Additive Manufacturing Thoracolumbar Fusion Matching Prosthesis System Class III Medical Devices Approved by the National Medical Products Administration CI
AK Medical’s Bone Reconstruction Medical Device Gets Certification in China MT
AK Medical Holdings Limited Announces Obtaining the Certification for the Trauma Custom Bridge Class III Medical Devices Approved by the National Medical Products Administration CI
More news
1 day+4.15%
1 week+19.96%
Current month+17.28%
1 month+25.43%
3 months+20.46%
6 months-20.19%
Current year-7.83%
More quotes
1 week
4.64
Extreme 4.64
5.82
1 month
4.59
Extreme 4.59
5.82
Current year
3.89
Extreme 3.89
6.35
1 year
3.89
Extreme 3.89
11.00
3 years
3.50
Extreme 3.5
16.28
5 years
3.41
Extreme 3.41
27.65
10 years
1.75
Extreme 1.75
27.65
More quotes
Managers TitleAgeSince
Founder 54 17/15/17
Chief Executive Officer 56 17/15/17
Director of Finance/CFO 40 01/16/01
Members of the board TitleAgeSince
Director/Board Member 63 29/16/29
Director/Board Member 49 17/17/17
Chief Executive Officer 56 17/15/17
More insiders
Date Price Change Volume
26/24/26 5.77 +4.15% 1,852,000
25/24/25 5.54 -0.18% 2,587,100
24/24/24 5.55 +6.73% 3,669,000
23/24/23 5.2 +4.00% 3,821,000
22/24/22 5 +3.95% 2,074,300

Delayed Quote Hong Kong S.E., April 26, 2024 at 01:38 pm IST

More quotes
AK MEDICAL HOLDINGS LIMITED is a company principally engaged in the design, development, manufacture and distribution of orthopedic implants. The Company has commercialized the application of three dimensional (3D) printing technology in orthopedic joint and spine replacement implants, with a focus on hip and knee replacement implants. The Company’s 3D Accurate Construction Technology (ACT) solutions assist surgeons in simulating and planning for implant surgeries, simplify surgical processes, offer personalized surgical instruments and pre-surgery selected implants and improve patients’ recovery experience significantly. The Company sells its products mainly within the China market and to oversea markets such as United Kingdom.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
5.341 CNY
Average target price
7.438 CNY
Spread / Average Target
+39.26%
Consensus